BAVA (BAVA)

BAVA (BAVA) is a company listed on the NYSE ARCA.

As of Oct 23, 2026: returns 1 week -9.7%.

Bavarian Nordic A/S is a fully integrated vaccine company specializing in travel health and public preparedness. As of April 2026, the company has completed its transition from a R&D-heavy biotech to a commercially driven vaccine leader following the 2023 acquisition of Emergent BioSolutions' travel vaccine portfolio.

BAVA financial model: income statement, cash flow and balance sheet